Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

RISING

  • FDA Approval
  • April 16, 2025, 08:42 UTC
  • 52
  • 0 comments

FDA approve MESALAMINE

Comment Full text

MICRO LABS

  • FDA Approval
  • April 16, 2025, 08:42 UTC
  • 46
  • 0 comments

FDA approve LATANOPROST

Comment Full text

AUROBINDO PHARMA LTD

  • FDA Approval
  • April 16, 2025, 08:42 UTC
  • 48
  • 0 comments

FDA approve ALLOPURINOL

Comment Full text

PADAGIS US

  • FDA Approval
  • April 16, 2025, 08:42 UTC
  • 50
  • 0 comments

FDA approve SUCRALFATE

Comment Full text

AUROBINDO PHARMA LTD

  • FDA Approval
  • April 16, 2025, 08:42 UTC
  • 37
  • 0 comments

FDA approve ESOMEPRAZOLE MAGNESIUM

Comment Full text

HETERO LABS LTD V

  • FDA Approval
  • April 16, 2025, 08:42 UTC
  • 49
  • 0 comments

FDA approve IMATINIB MESYLATE

Comment Full text

SUN PHARM

  • FDA Approval
  • April 16, 2025, 08:42 UTC
  • 53
  • 0 comments

FDA approve DOXORUBICIN HYDROCHLORIDE

Comment Full text

DR REDDYS

  • FDA Approval
  • April 16, 2025, 08:42 UTC
  • 40
  • 0 comments

FDA approve TRIAMCINOLONE ACETONIDE

Comment Full text

AUROBINDO PHARMA LTD

  • FDA Approval
  • April 16, 2025, 08:42 UTC
  • 50
  • 0 comments

FDA approve RIVAROXABAN

Comment Full text

JUBILANT GENERICS

  • FDA Approval
  • April 16, 2025, 08:42 UTC
  • 53
  • 0 comments

FDA approve DEFERASIROX

Comment Full text
  • Previous
  • 154
  • 155
  • 156
  • 157
  • 158
  • Next

Search

News categories

  • Technical Exchange News(10597)
  • Event(2007)
  • SEC News(184706)
  • FDA Approval(9847)
  • Company Report(721)
  • Business News(122347)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin